or Try an Advanced Search...

    Technical Analysis for LSB - YS Biopharma Co. Ltd.

    Grade Last Price % Change Price Change
    F 0.60 2.56% 0.02
    LSB closed up 2.56 percent on Friday, June 21, 2024, on 49 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical LSB trend table...
    Date Alert Name Type % Chg
    Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 200 DMA Bearish 2.56%
    Expansion Breakdown Bearish Swing Setup 2.56%
    Wide Range Bar Range Expansion 2.56%
    Wide Bands Range Expansion 2.56%
    Gapped Down Weakness 2.56%
    Lower Bollinger Band Touch Weakness 2.56%
    Older End-of-Day Signals for LSB ...

       Recent Intraday Alerts

    Alert Time
    Up 5% 3 days ago
    Up 3% 3 days ago
    Up 2% 3 days ago
    Up 1% 3 days ago
    Up 10% 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    LSB Chart by TradingView
    Basic chart:

    Profile

    YS Biopharma Co. Ltd. engages in discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Infectious Diseases Vaccines Virology

    Is LSB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 3 LakeShore Biopharma Co., Ltd (NASDAQ:LSB): When Will It Breakeven?
    May 24 YS Biopharma Announces Name Change to LakeShore Biopharma
    May 7 YS Biopharma appoints Dave Chenn as interim CEO
    May 7 YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
    May 7 With 80% ownership, YS Biopharma Co., Ltd. (NASDAQ:YS) insiders have a lot riding on the company's future
    Apr 22 YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript
    Apr 18 YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
    Apr 16 YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
    Apr 9 YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
    Apr 3 YS Biopharma announces full repayment of $40M loan facility
    See more LSB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.6
    52 Week Low 0.351
    Average Volume 89,653
    200-Day Moving Average 0.66
    50-Day Moving Average 0.83
    20-Day Moving Average 0.79
    10-Day Moving Average 0.69
    Average True Range 0.08
    RSI (14) 35.06
    ADX 14.82
    +DI 16.62
    -DI 30.32
    Chandelier Exit (Long, 3 ATRs) 0.86
    Chandelier Exit (Short, 3 ATRs) 0.77
    Upper Bollinger Bands 1.02
    Lower Bollinger Band 0.56
    Percent B (%b) 0.09
    BandWidth 58.04
    MACD Line -0.06
    MACD Signal Line -0.04
    MACD Histogram -0.023
    Fundamentals Value
    Market Cap 55.83 Million
    Num Shares 93.1 Million
    EPS -0.57
    Price-to-Earnings (P/E) Ratio -1.05
    Price-to-Sales 0.07
    Price-to-Book 0.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.70
    Resistance 3 (R3) 0.71 0.68 0.69
    Resistance 2 (R2) 0.68 0.66 0.68 0.68
    Resistance 1 (R1) 0.64 0.64 0.66 0.63 0.68
    Pivot Point 0.61 0.61 0.62 0.61 0.61
    Support 1 (S1) 0.57 0.59 0.59 0.57 0.52
    Support 2 (S2) 0.54 0.57 0.54 0.52
    Support 3 (S3) 0.50 0.54 0.51
    Support 4 (S4) 0.50